Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.037 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.7 |